Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Assessment of Thyroid Carcinogenic Risk and Safety Profile of GLP1-RA Semaglutide (Ozempic) Therapy for Diabetes Mellitus and Obesity: A Systematic Literature Review
Cătălin Vlăduț Ionuț Feier, Razvan Constantin Vonica, Alaviana Monique Faur, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4346-4346
Open Access | Times Cited: 15

Showing 15 citing articles:

How ‘miracle’ weight‐loss semaglutide promises to change medicine but can we afford the expense?
Ralf Weiskirchen, Amedeo Lonardo
British Journal of Pharmacology (2025)
Open Access | Times Cited: 3
From Medieval Scapegoating to Modern Conspiracy Theories in Healthcare
Milan Toma
(2025)
Closed Access | Times Cited: 3
From Medieval Scapegoating to Modern Conspiracy Theories in Healthcare
Milan Toma
(2025)
Closed Access | Times Cited: 2
Implications of GLP-1 Receptor Agonist on Thyroid Function: A Literature Review of Its Effects on Thyroid Volume, Risk of Cancer, Functionality and TSH Levels
Stefania Capuccio, Sabrina Scilletta, Francesca La Rocca, et al.
Biomolecules (2024) Vol. 14, Iss. 6, pp. 687-687
Open Access | Times Cited: 8
The safety, tolerability, pharmacokinetics and pharmacodynamics of GZR18 in healthy American and Chinese adult subjects
Yue Liu, Wei Chen, Xuemei He, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Exploring Connections Between Weight‐Loss Medications and Thyroid Cancer: A Look at the FDA Adverse Event Reporting System Database
Christophe Abi Zeid Daou, Omar Aboul Hosn, Lana Ghzayel, et al.
Endocrinology Diabetes & Metabolism (2025) Vol. 8, Iss. 2
Open Access
Glucagon-like peptide 1 receptor agonists and cancer risk: advancing precision medicine through mechanistic understanding and clinical evidence
Anqi Lin, Yanxi Ding, Zhengrui Li, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Comprehensive insights into emerging advances in the Neurobiology of anorexia
Liwei Mao, Lian Wang, Zhihai Huang, et al.
Journal of Advanced Research (2025)
Open Access
Enhancing diagnostic precision in thyroid nodule assessment: evaluating the efficacy of a novel cell preservation technique in fine-needle aspiration cytology
Diana-Raluca Streinu, Octavian Constantin Neagoe, Andreea Borlea, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 1
The Potential Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists as a Type of Conservative Treatment of Endometrial Cancer in Women of Reproductive Age: A Review of the Literature and a Call for Study
Maria Zoi Bourou, Alkis Matsas, Georgios Valsamakis, et al.
Cureus (2024)
Open Access | Times Cited: 1
Ozempic (semaglutide) - review of pharmacological properties, mechanism of action and clinical applications
Anna Maria Koman, Sabina Przygodzka, Katarzyna Gadżała, et al.
Quality in Sport (2024) Vol. 16, pp. 52659-52659
Open Access
Second Generation Anti-Obesity Medications
Sri Nikhita Chimatapu, Steven D. Mittelman, Vibha Singhal
Current Pediatrics Reports (2024) Vol. 12, Iss. 4, pp. 138-146
Closed Access
Sentinel Lymph Node Biopsy in Breast Cancer Using Different Types of Tracers According to Molecular Subtypes and Breast Density—A Randomized Clinical Study
Flaviu Ionuț Faur, Amadeus Dobrescu, Ioana Adelina Clim, et al.
Diagnostics (2024) Vol. 14, Iss. 21, pp. 2439-2439
Open Access
Potential Use of GLP-1 and GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at?
Miodrag Janić, Sabina Škrgat, Matevž Harlander, et al.
Medicina (2024) Vol. 60, Iss. 12, pp. 2030-2030
Open Access
Semaglutide (Ozempic ® ): a comprehensive review of its pharmacology, efficacy, and safety profile in type 2 diabetes mellitus and weight management
SD Vambe, W Zulu, E Hough, et al.
SA pharmaceutical journal. (2024) Vol. 91, Iss. 6, pp. 31-34
Closed Access
Page 1

Scroll to top